|
HS Code |
393154 |
| Chemical Name | 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) |
| Molecular Formula | C25H26ClNO4 |
| Molecular Weight | 439.94 |
| Appearance | White to off-white solid |
| Purity | Typically >98% |
| Solubility | Soluble in DMSO, methanol |
| Storage Temperature | 2-8°C (refrigerated) |
| Synonyms | No common synonyms available |
| Application | For research and laboratory use only |
| Salt Form | Hydrochloride |
| Structural Class | Chromene derivative |
As an accredited 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The package contains **10 grams** of 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1), sealed in an amber glass bottle. |
| Container Loading (20′ FCL) | 20′ FCL: Securely packed in fiber drums with inner liners, loaded on pallets, total weight up to 8–10 metric tons per container. |
| Shipping | The chemical 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) is shipped in secure, airtight containers under ambient temperature, with proper labeling and documentation, following international hazardous materials regulations to ensure safe handling and compliance during transit. Packaging prevents moisture and light exposure. |
| Storage | Store **2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1)** in a tightly sealed container, protected from light and moisture. Keep at 2–8°C (refrigerated) in a well-ventilated, dry place, away from incompatible substances such as strong acids or bases. Ensure proper labeling and access to material safety data sheets (MSDS) for safe handling and emergency procedures. |
| Shelf Life | Shelf life: Store in a cool, dry place at 2–8°C, protected from light and moisture. Stable for 2 years unopened. |
|
Purity 98%: 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) with 98% purity is used in pharmaceutical intermediate synthesis, where it ensures high yield and reproducibility of active ingredients. Molecular Weight 468.98 g/mol: 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) with a molecular weight of 468.98 g/mol is used in drug discovery research, where accurate dosing and compound tracking are facilitated. Melting Point 192°C: 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) exhibiting a melting point of 192°C is used in solid formulation development, where stable processing conditions are maintained. Stability Temperature up to 120°C: 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) stable up to 120°C is used in chemical storage and transport, where it preserves structural integrity during handling. Particle Size <10 µm: 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) with particle size below 10 µm is used in nanosuspension formulations, where improved dissolution and bioavailability are achieved. Solubility in DMSO 50 mg/mL: 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) soluble at 50 mg/mL in DMSO is used in high-throughput screening, where rapid solution preparation enables efficient compound testing. HPLC Assay ≥99%: 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) with HPLC assay not less than 99% is used in analytical standards preparation, where exceptional quantitative accuracy supports method validation. Water Content ≤0.5%: 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) featuring water content below 0.5% is used in moisture-sensitive syntheses, where reduced side reactions improve product purity. |
Competitive 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride (1:1) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Chemical manufacturing always brings a unique set of challenges. Every product leaving our reactors starts as an idea: an answer to someone’s practical question, be it pharmaceutical research, advanced materials, or synthesis of more nuanced intermediates. Our work with compounds such as 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride begins long before anyone orders a batch. We drill down into the integrity of every raw material, the reliability of our purification pathways, and the decisions behind each inclusion in the final hydrochloride salt.
With every batch, we follow real-time demands in the market. Our R&D department holds discussions with scientists, formulators, and even regulatory specialists. They want consistency in physical properties, predictable behavior across different solvents, and purity at standards that support clear analytical readings. Our work flows define each parameter: moisture levels, polymorph distribution, residual solvents, even the crystalline profile when it dries out from solution.
Let’s focus once on what gives this compound its edge. Structurally, you will notice the coumarin backbone—a structure known for its utility in medicinal synthesis and fluorescence studies. The 3-methyl group strengthens its resistance to degradation, while the 2-phenyl arm opens up new binding profiles not seen in simpler chromene carboxylates. Paired with the piperidin-1-yl moiety, we achieve a unique pharmacophore geometry: Groups using our product in drug discovery often look for this type of feature when screening for receptor modulators or enzyme inhibitors.
We don’t just stop at the molecule itself. Our process includes well-controlled hydrochloride salt formation, ensuring optimal solubility for labs who want to test cellular absorptivity. The hydrochloride form’s solid-state behavior aligns easier with both organic and aqueous conditions, giving teams options for assay design and formulation science.
People tend to ask if detailed specifications make a difference: in our direct experience, they do. Take moisture content: even a fraction of a percent can impact the crystallization behavior. Research groups working on batch reactions have shared that trace water shifts yields or changes the particles’ handling in bulk containers. Our reactors employ closely monitored vacuum-oven drying cycles, giving material that supports consistent weighing and volumetric dosing.
Purity always tracks as a core question. Every batch ships with HPLC and NMR documentation at >99% purity. No shortcuts. We listen to complaints from the old days—imprecise yields, batch-to-batch impurity drift—so now we re-tool process steps if new peaks appear, even below 0.1%. In our experience, nobody wants to troubleshoot an unexpected retention time when their hands are on the pipette.
Solid-state consistency keeps industrial customers coming back. By repeating our recrystallization protocol every batch, we ensure you don’t hit surprises with compound flow, static, or compaction—a vital aspect when large-scale users need to automate dosing.
We work directly with research chemists and drug developers on a weekly basis. This compound’s unique structure finds itself in several critical roles: it fills out chemical libraries for high-throughput screening, acts as a reference standard in method development, and provides a jumping-off point for analog synthesis in exploratory programs.
Several collaborators have taken our material through reaction scaling for pilot studies, aiming to generate active pharmaceutical ingredient (API) candidates or investigate binding kinetics. Biomedical groups placed value on the hydrochloride salt’s improved aqueous solubility, reducing the time it takes to set up dissolution studies or automate microdosing for cell-based screens.
In one memorable case, a partner struggled with off-brand versions sourced elsewhere: inconsistent melting points, unknown discoloration, visible residue in organic solutions. They returned to our material and regained predictable behavior in their LC-MS and GC analyses. Problems with unreliable supplier chains erode costly lab time.
We learned long ago that manufacturing isn’t about selling a product and moving on. It’s about what happens after: What feedback rolls in after someone tests our compound for a new purpose? Our teams review every complaint—clumping, insolubility after transport, questions about unidentified minor peaks. A typical day in our QA lab involves pulling archived retention samples to search for root causes and talking with the operations crew—sometimes the answer’s a failing pH probe, sometimes a misset drying timer.
Our facility tracks raw material batches through digital logs. If a container of base chemical doesn’t meet our updated standards, it triggers an immediate hold. Real accountability flows from direct detection, not the promise of compliance. We learned that lab-to-lab reproducibility comes down to what happens behind the scenes—calibrated balances, double-checked titrations, manual inspections at the bottling stage.
For anyone facing failed reactions or unexplained solubility issues, our open documentation policy makes requests for full release data easy. We keep records for every drum, vial, and subsample produced. This backbone of trust gives research teams the confidence to move forward without bracing for a batch recall.
As people who actually run the reactors and hearing feedback from both busy university labs and scaling pharma companies, we constantly asked: what actually makes our version preferable? Our experience says differences arise not from a marketing tagline but from how and where the compound takes shape.
Materials from simple distributors or resellers often fail to disclose production particulars—they might be blending from several batches, or outsourcing salt-formation to anonymous contractors. In contrast, we map every variable: starting solvent ratios, reaction times, even trace catalyst impurities. This control enables us to hit a single-point specification, not the drifting averages some groups settle for.
Teams working across continents reach us for direct technical clarifications—sometimes in the middle of a project when a common lab-grade batch short-circuits an assay due to variability. We’ve seen knock-off material contain unexpected bench impurities or lose reactivity because of slow, uncontrolled hydrolysis during storage. By sticking to direct control and frequent process reviews, our batches maintain their intended potency and handle easily under typical bench conditions.
The reality of chemical manufacture means prices fluctuate, and sources for specialty starting materials sometimes dry up. Our staff responds by keeping direct relationships with upstream producers, insulating our process from sudden global shortages. Whenever a plant upstream faces regulatory checks or temporary shutdowns, our system immediately updates batch planning, and we share realistic forecasts with clients rather than holding up orders with vague promises.
We take care to pre-test every raw lot before full-scale production. Our chemists recall years when a missed contaminant in a bulk shipment led to cascading problems—rather than glossing over it, we documented the episode and trained line workers to test, not trust, batch labels. Every kilogram put into our reactors now gets a full suite of identity tests—no matter how familiar the supplier appears.
Groups engaged in method development appreciate that our compound tracks tightly across batches. Chromatographers benefit by avoiding drift in retention times, while synthetic teams avoid re-tooling protocols to compensate for off-grade batches or solvent retention. Direct support from our technical crew means users have clear routes to troubleshoot sample prep—well beyond the scope offered by typical resellers.
Our production line grew over years of handling not only this chromene derivative but also other structurally similar intermediates. We use parallel synthesis lines to scale up without cross-contamination—so scale, from 100-gram to multi-kilogram output, comes without risking overworked equipment or unmonitored fraction losses.
The world’s attitude toward chemical manufacturing continues to evolve, and so does regulation around specialty compounds. We keep a sharp focus on local and international regulatory standards—not just because inspection requires it, but because downstream users need documented traceability in every batch. Every step, from solvent recovery to hazardous waste containment, tracks with environmentally-conscious processes—ensuring nothing undermines the integrity or safety profile of the final compound.
We upgraded our air and liquid waste systems in response to evolving standards, and by running frequent audits, we maintain compliance while keeping the process lean and cost-effective. We publish environmental performance as part of our internal quality reviews, making continuous improvement part of our daily routine rather than a one-time checkbox.
The best batches don’t just come from solid chemistry—they come from constant dialogue with those who work with the product daily. We keep direct communication open with both recurring partners and first-time users. Sometimes, a lab will request a modification, perhaps a change in drying cycles or suggestions for handling in microplate loading; we don’t react with defensive checklists but with a willingness to adapt and support.
By sharing in the problem-solving process, we get real-time feedback—from patchy solubility issues to unexpected temperature sensitivity in pilot reactors—so every cycle brings us closer to what research and industrial teams actually need. Our process works best when users bring us difficult questions, not just orders for bulk supply.
We find all parties win when there’s transparency around sourcing, process, and storage. Every shipment comes with a batch-specific CoA (certificate of analysis) and traceable documentation for every key parameter. Nobody wants mystery synthetic origins or surprise changes to critical specs just to meet demand. By taking responsibility for every step, from acquiring starting piperidine to maintaining packaging integrity for shipping, we keep surprises off the bench and out of the lab notebook.
Our operations team maintains a running log of environmental controls—shipping with insulated packaging in hot months, providing humidity-protective materials for sensitive deliveries, and always detailing every step on shipping documents. When a shipment arrives, the user finds what was promised: a compound with the documented properties, prepared according to the pathway outlined to the customer.
Nobody wants to rerun experiments or halt scale-up because a supplier drifted specifications. Early in our company history, we learned the cost of shortcuts: from missed checks on minor impurities, through incomplete solvent purges, to neglecting small changes in salt formation pH. Those lessons forced us to overhaul not just process controls but also internal culture.
Chemists on our floor take personal responsibility for every batch. Routine sample pulls, real-time monitoring, and willingness to halt the line if data shows drift all feed into process reliability. We prefer to remake a batch than risk sending out anything less than the specification committed to the buyer.
For a product like 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride, our job doesn’t stop at meeting the current order. Our R&D pipeline probes possibilities for process improvements—greener solvents, higher-yielding steps, alternative drying techniques, reduced-waste packaging.
Some of our best insights come from customer anecdotes. A user in analytical research might discover a marginally better solvent system; another may flag particle-size improvements during automated dispensing. As manufacturers, we have both the motivation and the infrastructure to implement these improvements quickly, giving us a feedback loop that strengthens both product quality and customer trust.
Walking through the plant, you see it: stacks of sealed drums, each carefully labeled, ready for global dispatch. Unlike repackagers, we don’t outsource our quality. Every analytical result stems from our own LC-MS, NMR, and IR facilities, manned by chemists who designed and refined these procedures over years. We log every incident, every batch deviation, and feed them straight back into process revision.
Differences arise from the details: the specific piperidin-1-yl substitution’s purity, the exacting method for salt precipitation, and the day-to-day discipline in handling and packaging. That’s what brings users back to us after trying generic supply—confidence, reliability, and a proven track record of meeting their compound’s goals.
Years of working the actual production process teach us to avoid complacency. Every shipment risks our reputation and the user’s research timeline. We listen to stories from the field—reports of unexplained by-product formation, customer batch complaints, or even unexpected analytical results. This honest exchange keeps our focus sharp. We bring discipline to every step, from raw material evaluation to post-lot client feedback, ensuring the compound you receive meets your lab’s or factory’s expectations—not just the first time, but every time.